REQUEST A DEMO
Total
USD $0.00
Search more companies

Meditek Life Sciences Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Meditek Life Sciences Private Limited Profile Updated: May 18, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Meditek Life Sciences Private Limited is an unlisted company, incorporated on 11/02/2003. It has its registered office in the State of Gujarat, India. Company's corporate identification number (CIN) is U24231GJ2003PTC041982 and registration number is 041982. The company is a trade company, it is engaged in wholesale trading.

Legal Address
D-1310, Sun Central Place, Nr. Vakil Saheb Bridge, S.P. Ring Road, Ambali,
Ahmedabad; Gujarat; Postal Code: 380058

Contact Details: Purchase the Meditek Life Sciences Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Meditek Life Sciences Private Limited report to view the information.
Outstanding Shares:
Purchase the Meditek Life Sciences Private Limited report to view the information.
Registered Capital:
Purchase the Meditek Life Sciences Private Limited report to view the information.
Incorporation Date:
February 11, 2003
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Professional Director
Purchase this report to view the information.
Whole Time Director
Purchase this report to view the information.
Managing Director
Company Performance
Financial values in the chart are available after Meditek Life Sciences Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
-32.8%
Total operating revenue
-32.75%
Operating profit (EBIT)
16.63%
EBITDA
9.5%
Net Profit (Loss) for the Period
16.72%
Total assets
-28.89%
Total equity
47.38%
Operating Profit Margin (ROS)
1.18%
Net Profit Margin
0.87%
Return on Equity (ROE)
-8.44%
Debt to Equity Ratio
-53.37%
Quick Ratio
0.29%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?